New retrospective study indicates that the shift of treatment from systemic chemotherapies to liver-directed therapies provides survival benefits.
We interview Jefferson researcher on how he is synthesizing molecules that could help treat diseases like cancer, with the help of a little blue light.
In patients with dementia, a sleep-dependent mechanism may link accumulation of beta-amyloid in the brain to cognitive impairment.
Creating a promising cancer vaccine from scratch is a multigenerational effort.
In women with uterine fibroids, the drug elagolix suppresses ovarian hormone production and prevents heavy menstrual bleeding.
New Jefferson cancer repository will house tissue samples from several cancer types for research purposes.
The famous cancer gene p53, which was thought to be less relevant in kidney cancer, may play a larger role than previously appreciated, suggesting new potential for treatment.
An interdisciplinary team of researchers explore how women use the social media platform to talk openly about the emotional distress of a miscarriage and how social media can inform patient care
Fatty liver disease is serious but preventable. Learn if you’re at risk.
Using a new sequencing method, this class of previously invisible RNA molecules were found to be abundantly expressed.
For news not listed on this page view the Jefferson News Archive.